Drug Scheduling Actions

Proposed Rule: Placement of Lorcaserin Into Schedule IV (December 19, 2012)

Final Order: Extension of Temporary Placement of Methylone Into Schedule I of the Controlled Substances Act (October 18, 2012)

Proposed Rule: Placement of Methylone Into Schedule I (October 17, 2012)

Final Rule: Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act (July 30, 2012)

Proposed Rule: Placement of Five Synthetic Cannabinoids Into Schedule I (March 1, 2012)

Final Order: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act (February 29, 2012)

Electronic Prescriptions for Controlled Substances

Correction: Definitions Relating to Electronic Orders and Prescriptions for Controlled Substances (September 24, 2012)

Notice: Electronic Prescriptions for Controlled Substances Notice of Approved Certification Process (August 1, 2012)

General

Proposed Rule: Disposal of Controlled Substances (December 21, 2012)

Final Rule: Consolidation of Seizure and Forfeiture Regulations (September 12, 2012)

Final Rule: Technical Amendments and Corrections to DEA Regulations (January 27, 2012)

Registration

Final Rule: Controlled Substances and List I Chemical Registration and Reregistration Fees (March 15, 2012)

Supporting and Related Material:

New Registrant Fee Schedule Calculations - Diversion Control Fee Account (PDF) (March 12, 2012)

ECONOMIC IMPACT ANALYSIS of Final Rule on Controlled Substances and List I Chemical Registration and Reregistration Fees, DEA-346 (PDF) (March 12, 2012)

DEA Registrant Letter (PDF) (March 12, 2012)

Registration Fees Fact Sheet (PDF) (March 12, 2012)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).